Research Funded by Box Rallies

A new approach to boosting resistance to fungal infection in cancer patients

A new therapeutic opportunity for gastrointestinal cancers

A patient-derived discovery platform for companion biomarker development in prostate cancer

Advanced pre-clinical evaluation of sphingosine kinase 1-targeting agents as a therapy for acute myeloid leukaemia

Advancing CAR-T cell therapy for extracranial solid paediatric cancers

CAPP3: a randomized dose finding non inferiority study of aspirin to prevent cancer in Lynch Syndrome

Creating the Next Generation in Radiotherapy Imaging with Carbon Nanotube Sources and Photon Counting Detectors

Defining the cellular determinants that drive dynamin inhibitor induced cell death and in vivo efficacy against glioblastoma

Defining the circulating genome of high-risk plasma cell disorders to improve risk stratification and clinical management

Defining the critical role of osteoclasts in multiple myeloma cell growth and activation in bone

Developing a Patient-Reported Symptom Index for Non-muscle Invasive Bladder Cancer

Developing a new blood-based screening test for bowel cancer

Developing a novel targeted therapy for treating chemotherapy-resistant leukaemia

Developing inhibitors of the LMO4 oncoprotein

Developing less toxic treatment approaches for childhood brain cancer

EAGLE FM Study: EvaluAtion of Groin Lymphadenectomy Extent For metastatic Melanoma

Effects of increased colonic butyrate on inherited colon cancer

Engineering childhood cancer for precision medicine